Suppr超能文献

海得霉素 II 型聚酮合酶酮还原酶(HedKR)的结构和生化研究:立体和区域特异性的分子基础。

Structural and biochemical studies of the hedamycin type II polyketide ketoreductase (HedKR): molecular basis of stereo- and regiospecificities.

机构信息

Department of Molecular Biology and Biochemistry, University of California, Irvine, Irvine, California 92697, United States.

出版信息

Biochemistry. 2011 Aug 30;50(34):7426-39. doi: 10.1021/bi2006866. Epub 2011 Aug 8.

Abstract

Bacterial aromatic polyketides that include many antibiotic and antitumor therapeutics are biosynthesized by the type II polyketide synthase (PKS), which consists of 5-10 stand-alone enzymatic domains. Hedamycin, an antitumor antibiotic polyketide, is uniquely primed with a hexadienyl group generated by a type I PKS followed by coupling to a downstream type II PKS to biosynthesize a 24-carbon polyketide, whose C9 position is reduced by hedamycin type II ketoreductase (hedKR). HedKR is homologous to the actinorhodin KR (actKR), for which we have conducted extensive structural studies previously. How hedKR can accommodate a longer polyketide substrate than the actKR, and the molecular basis of its regio- and stereospecificities, is not well understood. Here we present a detailed study of hedKR that sheds light on its specificity. Sequence alignment of KRs predicts that hedKR is less active than actKR, with significant differences in substrate/inhibitor recognition. In vitro and in vivo assays of hedKR confirmed this hypothesis. The hedKR crystal structure further provides the molecular basis for the observed differences between hedKR and actKR in the recognition of substrates and inhibitors. Instead of the 94-PGG-96 motif observed in actKR, hedKR has the 92-NGG-94 motif, leading to S-dominant stereospecificity, whose molecular basis can be explained by the crystal structure. Together with mutations, assay results, docking simulations, and the hedKR crystal structure, a model for the observed regio- and stereospecificities is presented herein that elucidates how different type II KRs recognize substrates with different chain lengths, yet precisely reduce only the C9-carbonyl group. The molecular features of hedKR important for regio- and stereospecificities can potentially be applied to biosynthesize new polyketides via protein engineering that rationally controls polyketide ketoreduction.

摘要

细菌芳香族聚酮类化合物包括许多抗生素和抗肿瘤治疗药物,由 II 型聚酮合酶(PKS)生物合成,该酶由 5-10 个独立的酶结构域组成。Hedamycin 是一种抗肿瘤抗生素聚酮类化合物,它的独特之处在于它由 I 型 PKS 生成的六烯基基团引发,然后与下游的 II 型 PKS 偶联,生物合成一个 24 碳的聚酮,其 C9 位由 hedamycin II 型酮还原酶(hedKR)还原。HedKR 与放线紫红素 KR(actKR)同源,我们之前对其进行了广泛的结构研究。HedKR 如何能够容纳比 actKR 更长的聚酮类化合物底物,以及其区域和立体特异性的分子基础,尚不清楚。本文详细研究了 hedKR,揭示了其特异性。KR 的序列比对表明 hedKR 的活性低于 actKR,在底物/抑制剂识别方面存在显著差异。体外和体内 hedKR 测定证实了这一假设。hedKR 晶体结构进一步为观察到的 hedKR 和 actKR 在底物和抑制剂识别方面的差异提供了分子基础。与在 actKR 中观察到的 94-PGG-96 基序不同,hedKR 具有 92-NGG-94 基序,导致 S 主导的立体特异性,其分子基础可以通过晶体结构来解释。结合突变、测定结果、对接模拟和 hedKR 晶体结构,提出了一个观察到的区域和立体特异性模型,阐明了不同的 II 型 KR 如何识别具有不同链长的底物,但却能精确地仅还原 C9-羰基。hedKR 对区域和立体特异性重要的分子特征可应用于蛋白质工程,通过合理控制聚酮酮还原来生物合成新的聚酮类化合物。

相似文献

9

引用本文的文献

9
Engineering polyketide synthases and nonribosomal peptide synthetases.工程化聚酮合酶和非核糖体肽合成酶。
Curr Opin Struct Biol. 2013 Aug;23(4):603-12. doi: 10.1016/j.sbi.2013.06.012. Epub 2013 Jul 6.

本文引用的文献

4

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验